Earnings
Advancing proprietary pipeline; solid progress in partnered programs
Ultragenyx Pharmaceutical Inc. today reported its financial results and corporate update for the quarter ended September 30, 2018.
Recipharm will publish its interim report for January-September 2018 on the 8th November at 07:45 am CET.
Neos Therapeutics, Inc. today announced that it will report third quarter 2018 financial results prior to the opening of U.S. financial markets on Friday, November 9, 2018.
ZEJULA® Q3 net sales totaled $63 million compared to $39 million for Q3 2017
Esperion today provided bempedoic acid franchise development program updates and financial results for the third quarter ended September 30, 2018.
Pivotal programs enrolling towards first data readout in 2019
Catalyst Pharmaceuticals, Inc. today announced that it will release third quarter 2018 financial results after market close on Wednesday, November 7, 2018.
The Hydroponics Company Limited, to be renamed THC Global Group Limited is pleased to provide an update to the market of its activities for the quarter ended 30 September 2018 (the Quarter).
Nanollose Limited is pleased to provide its Appendix 4C cash flow statement for the quarter ending 30 September 2018, together with the following operational update.
PRESS RELEASES